MK-677 Ibutamoren Guide: Research, Uses and Cycle Information

MK-677, Ibutamoren and MK-0677 are names used for the same investigational growth-hormone secretagogue. It is commonly grouped with SARMs in the performance market, but it does not act through the androgen receptor and is not technically a selective androgen receptor modulator.

What Is MK-677 Ibutamoren?

MK-677 is an orally active, non-peptide growth-hormone secretagogue. It was developed to stimulate the body’s own growth-hormone signalling without requiring an injected peptide or growth-hormone product.

Ibutamoren, MK-677 and MK-0677 refer to the same compound. LUM-201 is a later development name used in clinical research involving growth-hormone deficiency.

MK-677 remains investigational. It is not approved as a general muscle-building, recovery, anti-ageing or athletic-performance medicine.

Is MK-677 a SARM?

No. MK-677 does not belong to the selective androgen receptor modulator class.

True SARMs such as Ostarine, LGD-4033 and RAD-140 bind to androgen receptors. MK-677 instead activates the growth-hormone secretagogue receptor, also known as the ghrelin receptor.

It is commonly sold alongside SARMs because it appears in the same performance-focused market and is sometimes included in SARM stacks. That commercial grouping does not change its compound classification.

How Does MK-677 Work?

MK-677 acts as an agonist of the ghrelin receptor. Ghrelin-receptor activation can stimulate the pituitary gland to release growth hormone.

This can increase pulsatile growth-hormone secretion and raise insulin-like growth factor 1, commonly abbreviated as IGF-1. MK-677 stimulates endogenous signalling rather than supplying injected growth hormone directly.

Because the ghrelin receptor is also involved in appetite and metabolic regulation, MK-677 research has examined more than growth-hormone levels alone.

Human Research on Growth Hormone and IGF-1

Several controlled human studies have shown that MK-677 can increase growth-hormone secretion and IGF-1 concentrations.

A seven-day study in healthy young men found that oral MK-677 increased growth-hormone pulse amplitude and IGF-1. Earlier research in older adults also reported sustained stimulation of the growth-hormone and IGF-1 axis during daily administration.

These findings establish that MK-677 has measurable activity in humans. They do not establish a guaranteed change in muscle size, strength, recovery or physical appearance.

MK-677 and Fat-Free Mass

A randomized study followed healthy adults aged 60 to 81 who received MK-677 or placebo for approximately one year. The researchers reported that MK-677 increased pulsatile growth-hormone secretion and significantly increased fat-free mass.

The study did not report a significant reduction in total fat mass or abdominal visceral fat. Strength and functional outcomes also did not improve significantly.

Fat-free mass includes more than contractile muscle tissue. Changes in intracellular water, connective tissue and other lean components can contribute to the measurement, so an increase in fat-free mass should not automatically be described as an equivalent increase in visible muscle.

MK-677 During Calorie Restriction

A controlled crossover study evaluated MK-677 in eight healthy men during short-term calorie restriction. The researchers examined whether the compound could affect the negative nitrogen balance produced by restricted calorie intake.

MK-677 increased growth hormone and IGF-1 and reversed the measured diet-induced nitrogen loss during the treatment period.

This study contributed to interest in MK-677 for preserving lean tissue during calorie restriction. However, it was a small and short clinical experiment, not a bodybuilding cutting trial.

MK-677 and Body Fat

MK-677 should not be described as a direct fat-burning compound. Controlled studies have generally focused on growth hormone, IGF-1, nitrogen balance and fat-free mass rather than demonstrating reliable fat loss.

In the twelve-month older-adult study, total fat mass and abdominal visceral fat did not decrease significantly. Changes in body fat remain strongly influenced by calorie intake, nutrition, activity and training.

MK-677 and Sleep Research

Small controlled studies have investigated the effect of MK-677 on sleep architecture in younger and older adults.

Researchers reported changes in rapid-eye-movement sleep and slow-wave sleep during treatment. These findings contributed to performance-market discussions about sleep and recovery.

The studies were small and should not be used to guarantee better sleep for every user or to present MK-677 as an established treatment for insomnia or other sleep disorders.

Appetite and the Ghrelin Receptor

Ghrelin is closely involved in appetite signalling, which helps explain why increased appetite is frequently associated with MK-677 discussions.

Appetite response can vary. Increased food intake may work against a calorie-controlled cutting plan even when a compound is being researched for growth-hormone or body-composition effects.

MK-677 should therefore not automatically be categorized as a cutting product simply because it is sold alongside SARMs.

Blood Glucose and Insulin Sensitivity

Growth-hormone signalling can influence glucose metabolism. In the twelve-month study of older adults, fasting glucose increased modestly and insulin sensitivity declined during MK-677 treatment.

Other controlled research has also reported changes in glucose tolerance or insulin measurements. These findings are relevant when reviewing MK-677 and should not be omitted from its research profile.

Someone with existing glucose-control concerns requires appropriate medical evaluation rather than relying on general bodybuilding information.

Common MK-677 Cycle Discussions

Performance communities commonly discuss MK-677 use over longer periods than many traditional SARM cycles because it does not work through the androgen receptor.

Daily amounts commonly discussed online are often in the 10–25 mg range. These are non-medical community patterns rather than clinically approved bodybuilding protocols.

Human studies have used different amounts and durations depending on the population and research objective. Results from elderly adults, calorie-restricted volunteers or growth-hormone-deficient participants cannot automatically be transferred to healthy recreational users.

Does MK-677 Require PCT?

MK-677 is not an androgen receptor modulator and is not typically associated with testosterone suppression through the same mechanism as SARMs such as LGD-4033 or RAD-140.

For that reason, MK-677 used by itself is not generally the compound driving SARM PCT discussions. However, it is frequently combined with suppressive SARMs in performance-market stacks.

When MK-677 is used alongside a SARM, post-cycle considerations relate primarily to the androgen-receptor compounds included in the cycle. Those compounds should be evaluated individually rather than treating the entire stack as one product.

Available post-cycle products can be compared in the SARM PCT and Post-Cycle Support category.

MK-677 Compared With Ostarine

MK-677 and Ostarine are not members of the same compound class.

Ostarine MK-2866 is a selective androgen receptor modulator researched for lean body mass and physical function. MK-677 is a growth-hormone secretagogue researched for its effects on growth-hormone and IGF-1 signalling.

The Sarms Thailand Ostarine product contains 25 mg per ml, while MK-677 contains 20 mg per ml. Concentration does not provide a valid direct comparison because the compounds work through different biological pathways.

MK-677 Compared With LGD-4033

LGD-4033 Ligandrol binds to the androgen receptor and has produced measurable hormonal suppression in controlled human research.

MK-677 activates the ghrelin receptor and does not have the same androgen-receptor mechanism. Its important research considerations instead include growth-hormone, IGF-1, appetite and glucose metabolism.

They should therefore not be presented as interchangeable alternatives.

MK-677 in SARM Stacks

MK-677 appears in several pre-built packages alongside products such as RAD-140, LGD-4033, S-4 and Cardarine.

Only some of those compounds are true SARMs. Cardarine is a PPAR-delta agonist, while MK-677 is a growth-hormone secretagogue.

Combining several compounds creates a more complex cycle than using one product alone. Each ingredient has a separate mechanism, evidence base and monitoring consideration.

Current combinations can be reviewed in the SARM Stacks in Thailand category.

MK-677 Research Status

MK-677 remains an investigational compound. It has been administered in controlled human studies, but it is not approved as a general bodybuilding, muscle-building, recovery or athletic-performance medicine.

The compound remains under clinical investigation in selected medical research programs under development names including LUM-201.

Ibutamoren MK-677 is listed by the World Anti-Doping Agency among prohibited growth-hormone secretagogues. Athletes subject to drug testing should avoid products containing MK-677, MK-0677 or Ibutamoren.

Frequently Asked Questions

Are MK-677, Ibutamoren and MK-0677 the same compound?

Yes. Ibutamoren is the common compound name, while MK-677 and MK-0677 are development codes associated with the same substance.

Is MK-677 a real SARM?

No. MK-677 is a growth-hormone secretagogue and ghrelin-receptor agonist. It does not belong to the selective androgen receptor modulator class.

Does MK-677 increase growth hormone?

Controlled human studies have reported increased pulsatile growth-hormone secretion and higher IGF-1 concentrations during MK-677 treatment.

Did MK-677 increase muscle in human studies?

A twelve-month study reported increased fat-free mass, but it did not show significant improvements in strength or physical function. Fat-free mass should not be interpreted as an exact measurement of newly developed muscle tissue.

Does MK-677 burn fat?

Controlled research has not established MK-677 as a direct fat-loss compound. Total and abdominal fat did not decrease significantly in the twelve-month older-adult study.

How much MK-677 is in 1 ml?

In a liquid containing 20 mg per ml, one full millilitre contains 20 mg of MK-677.

Does MK-677 require SARM PCT?

MK-677 does not act through the androgen receptor and is not generally the compound responsible for SARM-related suppression. When it is combined with genuine SARMs, post-cycle considerations relate mainly to those androgen-receptor compounds.

MK-677 Research Sources

• Twelve-month randomized MK-677 study in healthy older adults
• MK-677 study during calorie restriction and nitrogen loss
• Controlled MK-677 sleep research
• Two-month MK-677 study in obese men
• PubChem information for Ibutamoren
• World Anti-Doping Agency Prohibited List